RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
批准号:
10064124
负责人:
Hilal Maradit Kremers
金额:
$65.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2023-11-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAmericanAmyloid beta-ProteinAutopsyBrainCase StudyCeramicsCharacteristicsChromiumChronicClinicClinicalCobaltCognitionCognitiveCorrosionDataDementiaEducationEligibility DeterminationEpidemicEpidemiologyExposure toFibrinogenFundingFutureGenotypeGoalsHip JointHip ProsthesisImmune responseImpaired cognitionImplantIndividualInfrastructureIonsKidney DiseasesKnee ProsthesisKnee jointKnowledgeLong-Term EffectsMeasuresMedical Record LinkageMetalsMonitorMorbidity - disease rateNegative FindingNerve DegenerationNeurocognitiveNeurocognitive DeficitObesityOperative Surgical ProceduresPatient riskPatientsPoliciesPolyethylenesPopulation StudyProceduresPublic HealthPublishingQuality of lifeRegistriesReplacement ArthroplastyResearchRiskRoleSafetySeriesSerumStructureSurfaceSynovial FluidSystemTimeTissuesTitaniumUnited Statescerebrovascular pathologyclinical riskcognitive functioncognitive testingcohortdata registrydata resourcedementia riskexperiencehigh riskimproved mobilitymortalityneuroimagingneuroimaging markerneurotoxicitypopulation basedprocedure safetyprospectivepublic health relevancerecruitsexvascular risk factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Total joint arthroplasty (TJA) is the fastest growing elective surgery in the nation. Over 7 million
Americans are currently living artificial hip or knee joints and this is expected to reach epidemic
proportions as a result of growing demand for improved mobility and quality of life. Although
TJA is a safe and effective procedure, there is growing concern about the long-term safety of
chronic exposure to TJA implants. Indeed, in a growing number of published case reports, TJA
is associated with neurocognitive deficits several years after surgery. Yet, the long-term effects
of implant debris from TJA implants on brain structure and cognitive function are unknown.
Large scale, population-based studies are needed to assess the potential contribution of chronic
exposure to TJA implant debris and subtypes (cobalt/chromium, polyethylene) to the risk of
cognitive decline and dementia. We propose to leverage the unique data resources of the
Rochester Epidemiology Project (REP, R01-AG034676), the Mayo Clinic Study of Aging
(MCSA, U01-AG006786) and the Mayo Alzheimer's Disease Research Center (ADRC; P50
AG016574) as well as the Mayo Clinic TJA registry to elucidate the long-term risk of dementia
and cognitive impairment in TJA patients.
Using 5-decades of historical data from the REP, we will compare the risk of dementia and
subtypes in population-based cohorts of TJA patients and matched non-TJA subjects adjusting
for well-known confounders (age, sex, obesity). We will further examine the risk according to
implant types. Using cross-sectional and longitudinal cognition and neuroimaging measures
collected as part of the MCSA cohort, we will determine whether cognitive status and
neuroimaging markers of cognitive function are worse in TJA patients compared with non-TJA
subjects. Finally, we will correlate metal ion levels with cognitive function and structural
changes on neuroimaging and postmortem tissues.
Successful completion of the proposed series of studies will be a key step towards
understanding whether chronic exposure to TJA implants is associated with cognitive
impairment. Our unique data resources offer a rare opportunity to efficiently address this
unknown risk. Potential downstream effects are significant including eligibility criteria for TJA,
and monitoring high risk TJA implants and patients who are most likely to suffer from systemic
effects. Even negative findings can exert a significant public health impact by providing
reassurance about the safety of TJA to millions of current and future TJA patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10318585
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:10453454
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10743158
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10477005
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10703442
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY
-
批准号:10532748
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:10204100
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Cardiotoxicity in Total Joint Arthroplasty
-
批准号:9980492
-
项目类别:
-
资助金额:$70.09万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Methodology Core
-
批准号:10019360
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2019
-
负责人:Hilal Maradit Kremers
-
依托单位:
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
-
批准号:10358647
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2018
-
负责人:Hilal Maradit Kremers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: